THE NEW ALIGNMENT: A SUMMARY
With the completion of its structural alignment, the combination of MedPlast and UPG represents, in total, 14 manufacturing locations worldwide.
UPG's former healthcare plants now operate under the MedPlast aegis. Today, the UPG brand operates two plants in China, one in Wales, and two in the U.S. The primary focus is on specialty Industrial markets, as noted earlier.
The MedPlast brand today includes nine facilities, which concentrate on the healthcare market. In addition to the original five U.S.-based MedPlast operations, these include UPG's former dedicated Healthcare facility and tooling operation in China, another in Mexico and two in the U.S.
ABOUT MEDPLAST AND UPG
MedPlast's expertise includes injection molding, liquid injection molding (LIM), two-shot molding, over molding, insert molding, multi-component molding, extrusion, blow molding, injection blow molding, injection stretch blow molding, silicone extrusion, compression and transfer molding, and precision mold making.
In addition, MedPlast offers complete solutions for processing elastomeric and silicone materials, as well as value-added capabilities such as partial- and full-assembly, contract sterilization, lab services as well as global supply chain and logistics management. With state of the art facilities in China, including precision mold making, MedPlast provides worldwide project management.
UPG is a full-service solutions provider with an expanding customer base focused upon industrial specialty markets. As a result of this new orientation, the brand has dramatically increased plant utilization and heightened its ability to win major on-shoring assignments.
The UPG brand is poised to provide greater choice for its customers and deliver superior return on investment through its unified quality system and
|SOURCE MedPlast, Inc.|
Copyright©2012 PR Newswire.
All rights reserved